Literature DB >> 8033121

Induction and expression of amphiregulin in human pancreatic cancer.

M Ebert1, M Yokoyama, M S Kobrin, H Friess, M E Lopez, M W Büchler, G R Johnson, M Korc.   

Abstract

The epidermal growth factor receptor is activated by a family of polypeptides that includes the growth factor amphiregullin (AR). Using Northern blot analysis and the polymerase chain reaction, we now report that AR mRNA is expressed in human pancreatic cancer cell lines, and that this expression is enhanced in several of these cell lines by tetradecanoyl phorbol acetate and transforming growth factor alpha. AR was also expressed in normal and malignant pancreatic tissues. However, in the normal pancreas, AR immunostaining was most evident in the nuclei of ductal cells. In contrast, in many carcinomas, AR was also present in the cytoplasm of the ductal-like cancer cells. Cytoplasmic localization of AR was associated with a more advanced clinical stage. These findings suggest that AR may contribute to aberrant activation of the epidermal growth factor receptor in human pancreatic cancer, and may enhance disease progression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8033121

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  39 in total

Review 1.  Molecular mechanism of pancreatic cancer--understanding proliferation, invasion, and metastasis.

Authors:  André L Mihaljevic; Christoph W Michalski; Helmut Friess; Jörg Kleeff
Journal:  Langenbecks Arch Surg       Date:  2010-03-18       Impact factor: 3.445

2.  Bak expression and cell death occur in peritumorous tissue but not in pancreatic cancer cells.

Authors:  H U Graber; H Friess; A Zimmermann; M Korc; G Adler; R Schmid; M W Büchler
Journal:  J Gastrointest Surg       Date:  1999 Jan-Feb       Impact factor: 3.452

3.  Overexpression of platelet-derived growth factor (PDGF) B chain and type beta PDGF receptor in human chronic pancreatitis.

Authors:  M Ebert; H U Kasper; S Hernberg; H Friess; M W Büchler; A Roessner; M Korc; P Malfertheiner
Journal:  Dig Dis Sci       Date:  1998-03       Impact factor: 3.199

4.  Topography of amphiregulin expression in cultured human keratinocytes: colocalization with the epidermal growth factor receptor and CD44.

Authors:  N Nylander; L T Smith; R A Underwood; M Piepkorn
Journal:  In Vitro Cell Dev Biol Anim       Date:  1998-02       Impact factor: 2.416

5.  Effector T lymphocyte subsets in human pancreatic cancer: detection of CD8+CD18+ cells and CD8+CD103+ cells by multi-epitope imaging.

Authors:  K Ademmer; M Ebert; F Müller-Ostermeyer; H Friess; M W Büchler; W Schubert; P Malfertheiner
Journal:  Clin Exp Immunol       Date:  1998-04       Impact factor: 4.330

6.  Potential roles for PA28beta in gastric adenocarcinoma development and diagnosis.

Authors:  Qiaojia Huang; Qingling Huang; Wansong Lin; Jianyin Lin; Xu Lin
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-06       Impact factor: 4.553

7.  Induction of TFF1 gene expression in pancreas overexpressing transforming growth factor alpha.

Authors:  M P Ebert; J Hoffmann; C Haeckel; K Rutkowski; R M Schmid; M Wagner; G Adler; H U Schulz; A Roessner; W Hoffmann; P Malfertheiner
Journal:  Gut       Date:  1999-07       Impact factor: 23.059

8.  Integrin α6β4 Promotes Autocrine Epidermal Growth Factor Receptor (EGFR) Signaling to Stimulate Migration and Invasion toward Hepatocyte Growth Factor (HGF).

Authors:  Brittany L Carpenter; Min Chen; Teresa Knifley; Kelley A Davis; Susan M W Harrison; Rachel L Stewart; Kathleen L O'Connor
Journal:  J Biol Chem       Date:  2015-09-17       Impact factor: 5.157

9.  Frequent expression of genes for receptor tyrosine kinases and their ligands in human pancreatic cancer cells.

Authors:  T Oikawa; J Hitomi; A Kono; E Kaneko; K Yamaguchi
Journal:  Int J Pancreatol       Date:  1995-08

10.  The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer.

Authors:  J Kleeff; T Ishiwata; A Kumbasar; H Friess; M W Büchler; A D Lander; M Korc
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.